Meihua International Medical Technologies Co., Ltd. · OTC:MHUAF

Meihua International Medical Technologies — IPO Roadshow (February 2022)

30 slides from Meihua International Medical Technologies's IPO roadshow presentation, Feb 3, 2022

  1. Slide 1: Meihua International Medical Technologies Investor Presentation

    Meihua International Medical Technologies Co., Ltd. Investor Presentation February 2022 Issuer Free Writing Prospectus Dated February 2, 2022 Filed Pursuant to Rule 433 Relating to Preliminary Prospectus Dated February 2, 2022 Registration Statement No. 333 - 258659

  2. Slide 2: Forward-Looking Statements

    Forward - Looking Statements This presentation includes statements that are, or may be deemed, “forward - looking statements”. In some cases these forward - look ing statements can be identified by the use of forward - looking terminology, including the terms “believes,” “estimates,” “anticipates,”

  3. Slide 3: Free Writing Prospectus Statement

    Free Writing Prospectus Statement This free writing prospectus relates to the proposed initial public offering of the ordinary shares (the “Ordinary Shares”), par value US $ 0 . 0005 per share, of Meihua International Medical Technologies Co . , Ltd . (the “ Company ” ), which are being registered o

  4. Slide 4: Offering Summary

    Issuer Meihua International Medical Technologies Co., Ltd. (“Meihua International”) Securities Ordinary Shares, par value US$0.0005 per share Ticker Nasdaq Global Market: MHUA Pre - Offering Ordinary Shares Outstanding 20,000,000 shares Number of Shares Offered 5,000,000 Post - Offering Shares Outst

  5. Slide 5: Table of Contents

    Table of Contents 01 02 03 04 05 Company Overview 6 Investment Highlight 10 Industry Overview 21 Growth Strategies 25 Financials 27

  6. Slide 6: Provider of Class I, II and III Disposable Medical Devices in China

    IcZoom Group Inc | Page 2 We are a Provider of Class I,II, and III Disposable Medical Devices in China ▪ Class II Medical Devices Devices with moderate risks, that must be strictly controlled and regulated to ensure their safety and effectiveness ▪ Class I Medical Devices Devices with low level of r

  7. Slide 7: Three Operating Subsidiaries in PRC

    distributes Class I, II and III disposable medical devices sourced from other manufacturers distributes Class I, II and III disposable medical devices sourced from other manufacturers Meihua International | Page 7 We operate our business through three operating subsidiaries in PRC Yangzhou Huada Med

  8. Slide 8: Our Multifaceted Revenue Model

    IcZoom Group Inc | Page 8 Our Multifaceted Revenue Model Sales from our own brands Resales from other brands • Manufacturing and sales of Class I, II, III disposable medical devices under our own brands • Resales of Class I, II, III disposable medical devices sourced by us from other manufacturers %

  9. Slide 9: International and Domestic Sales Models

    Meihua International | Page 9 1 Export medial devices through exporting distributors • 316 exporting distributors as of June 30, 2021 • Each distributor usually sells to at least 3 overseas customers 2 Deliver supplies to customers • Customers based in Europe, North America, South America, Asia, Afr

  10. Slide 10: Strong Sales & Distribution Network

    1. Strong Sales & Distribution Network established via over 40 - year operation Each distributor covers at least three overseas customers 316 exporting distributors Clients based in more than 30 countries in Europe, North America, South America, Asia, Africa and Oceania 900+ customers Supply medical

  11. Slide 11: Fully Licensed Manufacturer with Market-Oriented R&D

    • Sound quality assurance system • 20+ FDA certified products • ISO 13485 certification CE, FDA certified • Production license • Operation license • Export registration for Class I, II, and III medical devices Wholly licensed • Expert R&D crew of 78 people, 12.4% of our personnel • $2.5 million R&D

  12. Slide 12: Cost-Effective Methods with a Variety of Products

    Source: Prospectus & https:// www.iczoom.com / 3. Cost - effective methods to address customers’ significant needs with a variety of products 920 Products in Our Product Portfolio One - stop service: R&D, Production, Sales Covering all Class I, II, and III disposable medical devices Cost - effective

  13. Slide 13: Massive Distribution Network

    4. Massive distribution network of clients, distributors, and suppliers Hospitals Pharmacies Medical Institutions 83 Employees in our sales department 5,000 2,095 301 Independent sales agents Distributors for domestic sales Exporting distributors for overseas sales Company Overview Investment Highli

  14. Slide 14: Geographical Advantages for One-Stop Service

    5. Geographical advantages allow us to provide one - stop service to our customers at reduced cost Touqiao Town, Yangzhou City, Jiangsu Province One of the four medical device centers in PRC “Hometown of Medical Devices & Consumables in China” Our PRC operating subsidiaries and primary operations ar

  15. Slide 15: Economies of Scale and Automation

    Source: Prospectus & https:// www.iczoom.com / Increase Profit Margin Lower Procurement Costs • In the procurement process, the production scale reduces our procurement costs and mitigate the impact of raw material price fluctuations. • In the manufacturing process, we retrofitted equipment and intr

  16. Slide 16: Leading Position via High Quality Standard Systems

    7. Leading competitive position maintained by high quality standard systems Core Value Quality Management System Internal Control Standard System • Quality: We aim to become a world - leading manufacturer of medical consumables with high quality. • Safety: It depends on the effectiveness of our qual

  17. Slide 17: Market-Driven Research and Development

    8. Market - driven research and development allow for continual improvement and long - term client loyalty 78 $2,492,059 $3,214,326 R&D team of 78 people – 12.4% of our total employees Investment in the products and R&D in 20 20 : $2,492,059 Investment in the products and R&D in 20 19 : $3,214,326 M

  18. Slide 18: Visionary and Experienced Management Team

    9. Visionary and experienced management team Yongjun Liu – Founder and Chairman ▪ A successful entrepreneur with over 40 years experience in the medical device industry ▪ Awarded as Excellent Entrepreneur, Honest Entrepreneur Representative and Medical Device Industry Representative for many times ▪

  19. Slide 19: Management: CEO and CFO

    Yulin Wang, CEO and Director • Chief Executive Officer and Director since October 2020 • Chief Executive Officer of Kang Fu International Medical Co., Ltd. since March 2020 and Special Assistant to Chairman of Jiangsu Yada since October 2019 • From July 1985 to June 2016 (retired), successively serv

  20. Slide 20: Independent Director Nominees

    Xiaoming E, Independent Director Nominee • Director nominee of our Company who will become a director upon the effectiveness of this registration statement • From January 2010 to present, Chairman and General Manager of Jiangsu Changfeng Medical Industry Co., Ltd. • From May 2004 to present, • Vice

  21. Slide 21: Strictly Regulated Industry with Growth Potential

    01 Strictly regulated industry • Class I devices subject to recordation administration • Class II, III subject to registration administration High barriers to entry 02 Approved distributors • business license and disposable medical device operation license • exporting license • Sales channels and di

  22. Slide 22: China's Disposable Medical Device Market Size

    Company Overview Investment Highlights Industry Overview Growth Strategies Financials Market Size of China’s Low Value - added Disposable Medical Devices from 201 6 - 20 20 (Unit: RMB100 million, %) Global Low Value - added Disposable Medical Device Market Scale and China’s Market Share from 2016 -

  23. Slide 23: Regional Development of China's Disposable Medical Device Industry

    Regional Breakdown of China’s Disposable Medical Devices in 2019 (Unit: %) Qualification of China’s Medical Device Manufacturers in 2019 (Unit: number of companies) Regional Development of China’s Disposable Medical Device Industry Source: Collated by Forward ( Qianzhan ) Intelligence As the industr

  24. Slide 24: Medical Device Industry in Touqiao Town, Yangzhou

    Disposable Medical Device Industry Size in Touqiao Town, Yangzhou, Jiangsu Province from 2017 - 2019 (Unit: RMB100 million) Development of Medical Device Industry in Touqiao Town, Yangzhou City, Jiangsu Province Source: Collated by Forward ( Qianzhan ) Intelligence • Touqiao was named “The Town of D

  25. Slide 25: Growth Strategies: Market Share and Quality

    Company Overview Investment Highlights Industry Overview Growth Strategies Financials 1 . Solidify industry position by gaining additional market share 2. Uphold commitment to high quality products ▪ Participate in more expos or exhibitions for more exposure ▪ Expand production capacity through hori

  26. Slide 26: Growth Strategies: Distribution Network and Talent

    3. Expand sales and distribution network 4. Enhance abilities to attract, incentivize, and retain talented industry professionals Formulating a market - oriented employee compensation structure Implementing a standardized multi - level performance review mechanism Maintaining and improving competiti

  27. Slide 27: Financial Highlights

    1 2 3 Steady increase of revenue ($MM) 12% 4 High Gross Margin and Profit Margin Gross Margin Profit Margin Steady net income ($MM) Healthy Liquidity and Operating Cash Flow ($MM) Cash Operating Cash Flow 23% Company Overview Investment Highlights Industry Overview Growth Strategies Financials 2020:

  28. Slide 28: Appendix

    Appendix

  29. Slide 29: Onshore Offshore Corporate Structure

    Onshore Offshore Corporate Structure Meihua International Technologies Co., Ltd. (Cayman) Kang Fu International Medical Co., Ltd. (Hong Kong) Yangzhou Huada Medical Device Co., Ltd. (PRC) Jiangsu Yada Technology Group Co., Ltd. (PRC) Jiangsu Huadong Medical Device Industrial Co., Ltd. (PRC) Yangzhou

  30. Slide 30: Thank You

    THANK YOU Company Amy Zhu Meihua International Medical Technologies Co., Ltd. IR @ meihuamed .com +86 15366426268 Underwriters Frank Wang Prime Number Capital LLC [email protected] +86 15221989673 Investor Relations Janice Wang EverGreen CQ Consulting Inc. [email protected] +1 - 571 - 46

Meihua International Medical Technologies — IPO Roadshow (February 2022) on 6ix